Study of tumor-specific expression of some evolutionary new genes
Vol. 62 No. 3 (2016), Articles
Vol. 62 No. 3 (2016)

Study of tumor-specific expression of some evolutionary new genes

Articles
https://doi.org/10.37469/0507-3758-2016-62-3-495-500
Published 15.12.2016
St. Petersburg State Polytechnic University; Biomedical Center
St. Petersburg State University
St. Petersburg State Polytechnic University; Biomedical Center
St. Petersburg State Polytechnic University; Biomedical Center
St. Petersburg State Polytechnic University; Biomedical Center
PDF (Русский)

Keywords

DCD1
LINC00309
CLLU1
tumor-specific expression
evolutionary new genes

How to Cite

, , , , & . (2016). Study of tumor-specific expression of some evolutionary new genes. Voprosy Onkologii, 62(3), 495–500. https://doi.org/10.37469/0507-3758-2016-62-3-495-500
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Abstract

In this paper we have showed that evolutionary new genes DCD1(Dermicidin), LINC00309 (Long intergenic non-protein coding RNA 309) and CLLU1(Chronic lymphocytic leukemia up-regulated 1) have tumor-specific expression profile. Along with our previously published results this confirms the existence of the phenomenon of TSEEN (Tumor-Specifically Expressed, Evolutionarily Novel).
https://doi.org/10.37469/0507-3758-2016-62-3-495-500
PDF (Русский)

References

Круковская Л.Л., Самусик Н.А., Шилов Е.С. Опухолеспецифическая экспрессия эволюционно нового гена PBOV1 // Вопр. онкол. - 2010. - Т 56. - № 3. - С. 327-332.

Самусик Н.А., Галачьянц Ю.П., Козлов А.П. Анализ эволюционной новизны последовательностей, экспрессирующихся в опухолях // Экологич. генетика. -2009. - Т. VII. - № 2. - С. 26-37.

Baranova A.V., Lobashev A.V., Ivanov D.V. et al. In silico screening for tumour-specific expressed sequences in human genome // FEBS Lett. - 2001. - Vol. 508 (1). -P. 143-148.

Bos R., van Duikeren S., van Hall T. et al. Expression of a natural tumor antigen by thymic epithelial cells impairs the tumor-protective CD4+ T-cell repertoire // Cancer Res. -2005. - Vol. 65 (14). - P. 6443-6449.

Brauer H.A., D’Arcy M., Libby T.E. et al. Dermcidin expression is associated with disease progression and survival among breast cancer patients // Breast Cancer Res Treat. - 2014. - Vol. 144 (2). - P. 299-306.

Buhl A.M., Jurlander J., Geisler C.H. et al. CLLU1 expression levels predict time to initiation of therapy and overall survival in chronic lymphocytic leukemia // Eur J Haematol. - 2006. - Vol. 76 (6). - P. 455-464.

Buhl A.M., Jurlander J., Jrgensen F.S. et al. Identification of a gene on chromosome 12q22 uniquely overexpressed in chronic lymphocytic leukemia // Blood. - 2006. - Vol. 07 (7). - P. 2904-2911.

Chang W.C., Huang M.S., Yang C.J. et al. Dermcidin identification from exhaled air for lung cancer diagnosis // Eur Respir J. - 2010. - Vol. 35 (5). - P 1182-1185.

Clamp M., Fry B., Kamal M. et al. Distinguishing protein-coding and noncoding genes in the human genome // Proc Natl Acad Sci U S A. - 2007. - Vol. 104 (49) - P. 19428-19433.

Dobrynin P., Matyunina E., Malov S.V., Kozlov A.P. The novelty of human cancer/testis antigen encoding genes in evolution// Int J Genomics.- 2013.- Vol. 2013.- Article ID 105108.

Huijbers I.J., Soudja S.M., Uyttenhove C. et al. Minimal tolerance to a tumor antigen encoded by a cancer-germline gene // J. Immunol. - 2012. - Vol. 188 (1). -P. 111-121.

Josefsson P., Geisler C.H., Leffers H. et al. CLLU1 expression analysis adds prognostic information to risk prediction in chronic lymphocytic leukemia // Blood. - 2007. -Vol. 109 (11). - P. 4973-4979.

Knowles DG, McLysaght A. Recent de novo origin of human protein-coding genes // Genome Res. - 2009. -Vol. 19 (10) - P. 1752-1759.

Kozlov A.P. Evolution by Tumor Neofunctionalization: The role of Tumors in the Origin of New Cell Types and Organs // Academic Press/ Elsever. - 2014.

Kozlov A.P., Galachyants Y.P., Dukhovlinov I.V. et al. Evolutionarily new sequences expressed in tumors // Infect Agent Cancer. - 2006. - Vol. 25. - P. 1-8.

Krukovskaja L.L., Baranova A., Tyezelova T. et al. Experimental study of human expressed sequences newly identified in silico as tumor specific // Tumour Biol. -2005. - Vol. 26. - № 1. - P. 17-24.

Oppliger Leibundgut E., Rogenmoser-Dissler D., de Beer D. et al. CLLU1 expression distinguishes chronic lymphocytic leukemia from other mature B-cell neoplasms // Leuk Res. - 2012. - Vol. 36 (9) - P. 1204-1207.

Polev DE, Karnaukhova IK, Krukovskaya LL, Kozlov AP. ELFN1-AS1: a novel primate gene with possible microRNA function expressed predominantly in human tumors // Biomed Res Int. - 2014. - 2014:398097.

Porter D., Weremowicz S., Chin K. et al. A neural survival factor is a candidate oncogene in breast cancer // Proc Natl Acad Sci U S A. - 2003. - Vol. 100 (19). - P 10931-10936.

Rosenquist R., Cortese D., Bhoi S. et al. Prognostic markers and their clinical applicability in chronic lymphocytic leukemia: where do we stand? // Leuk Lymphoma. - 2013. - Vol. 54 (11). - P 2351-2364.

Sambrook J., Russel D.W. Molecular cloning: a laboratory manual // 3rd ed. New York: Cold Spring Harbor Laboratory Press, Cold Spring Harbor, 2001.

Samusik N., Krukovskaya L., Meln I. et al. PBOV1 is a human de novo gene with tumor-specific expression that is associated with a positive clinical outcome of cancer // PLoS One. - 2013.- Vol. 8 (2) - e56162.

Schittek B., Hipfel R., Sauer B. et al. Dermcidin: a novel human antibiotic peptide secreted by sweat glands // Nat Immunol. - 2001. - Vol. 2 (12). - P 1133-1137.

All the Copyright statements for authors are present in the standart Publishing Agreement (Public Offer) to Publish an Article in an Academic Periodical 'Problems in oncology' ...